Sign up
Quantellect · Congress · Issuer Profile
NYSE: OGNOrganon & Co
HealthcareMkt Cap $3.61BCongress ownership rank #625

Organon & Co Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 38 trades in Organon & Co (NYSE: OGN) since 2021, across 6 members, worth an estimated $1.8M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 15 buys against 23 sells, a modestly sell-led skew, with Democratic members responsible for 18% of the trades and Republican members 82%. The most recent disclosure shown was filed August 2026, and Kevin Hern has filed the most OGN transactions among those shown, with 2. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Organon & Co's current Quantellect Tide Score is 50 out of 100 (High Tide), Top 49% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Organon & Co (OGN) stock overview and the complete trade table below.

Data updated

Trades
2
Politicians
1
Filings
2
Disclosed Vol
$16.00K
Buys
0
0%
Sells
2
100%

Price & congressional trade timeline

Party breakdown

Organon & Co congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Aug 10, 2026Aug 5, 20265 daysSELL
$1,001 - $15,000
+1.33%Joint
Aug 12, 2026Aug 5, 20267 daysSELL
$1,001 - $15,000
+1.33%Joint
Go to

Organon & Co (OGN) congressional trading FAQ

Can members of Congress legally trade Organon & Co (OGN) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Organon & Co (OGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional Organon & Co (OGN) trades public?

Yes. Every congressional trade in Organon & Co (OGN) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Organon & Co (OGN)?

Members of Congress have disclosed 38 trades in Organon & Co (OGN) worth $1.8M across 6 members, according to public STOCK Act filings.

Which members of Congress have traded Organon & Co (OGN)?

Recent and active filers of Organon & Co (OGN) disclosures include Kevin Hern. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Organon & Co (OGN) more?

Across disclosed Organon & Co (OGN) trades, 18% were by Democrats and 82% by Republicans, led by Republicans (82%).

What is the most recent congressional Organon & Co (OGN) trade?

The most recent disclosed Organon & Co (OGN) trade was a sale by Kevin Hern, filed Aug 11, 2026.

What is Organon & Co (OGN)'s Tide Score?

Organon & Co (OGN) has a Quantellect Tide Score of 50 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewOrganon & Co (OGN) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.